Skip to content

A research study to evaluate the effectiveness of nasal drops with siddharthaka agada arka (an Ayurvedic herbal distillate medicine ) in patients suffering from depressive disorders.

An open label single arm clinical study on effectiveness of siddharthaka agada arka pratimarsha nasya in kaphaja unmada (depressive disorders)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030625
Enrollment
30
Registered
2021-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F330- Major depressive disorder, recurrent, mild Health Condition 2: F331- Major depressive disorder, recurrent, moderate Health Condition 3: F320- Major depressive disorder, singleepisode, mild Health Condition 4: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: Siddharthaka agada arka: Two drops siddharthaka agada arka in each nostril twice daily before food for 30 days. Control Intervention1: N/A: N/A

Sponsors

SDM college of ayurveda and hospital hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as per the criteria for mild and moderate depression as per ICD 10. 2. Age between 18 to 60 years. 3. Patients of either gender, irrespective of socioeconomic status. 4. Patients ready to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other psychiatric disorders like Schizophrenia, Bipolar mood disorder, and substance abuse. 2. Patients with severe depressive disorder. 3. Pregnant women. 4. Patients with other systemic disorders like uncontrolled Hypertension, Diabetes mellitus, Tuberculosis.

Design outcomes

Primary

MeasureTime frame
Improvement in the score of Hamilton depression scale, by the use of Siddharthaka agada arka pratimarsha nasya in the management of Kaphaja unmada (depressive disorders).Timepoint: outcomes will be assessed at baseline, 15 days and 30 days.

Secondary

MeasureTime frame
Hamilton Depression scaleTimepoint: 15 days, 30 days

Countries

India

Contacts

Public ContactDr Suhas Kumar Shetty

SDM college of ayurveda and hospital hassan

drsuhasshetty@sdmcahhassan.org9449603234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026